首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Development and validation of an individual risk prediction tool for severe respiratory syncytial virus infection among children under five years in China]. [中国五岁以下儿童严重呼吸道合胞病毒感染个体风险预测工具的开发与验证]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231206-00406
B B Cong, S Y Deng, S H Ma, Y M Miao, Y Li

Objective: To construct a predictive model to assess the risk of severe respiratory syncytial virus infection among children under five years in China, conduct preliminary validation of this model by using external data, and develop an individual risk assessment tool available for their parents. Methods: The admission after RSV infection was used as a marker of severe infection. Based on the evidence of RSV hospitalization-related risk factors and real-world data, such as the prevalence of various risk factors in children under five years old in China, a Monte Carlo-based individual RSV hospitalization risk prediction model for children under five years old was constructed. Taking Suzhou City as an example, the model was externally validated, and an interactive risk prediction tool (RSV HeaRT) was developed on the WeChat mini-program platform. Results: The estimation model showed that in children under five years old in China if the population did not have any risk factors for severe RSV infection, the RSV annual hospitalization rate was 2.2/1 000 (95%CI: 0.9/1 000-7.5/1 000). Based on this baseline hospitalization rate and the prevalence of related risk factors in Suzhou, the model predicted an RSV hospitalization rate of 8.0/1 000 (95%CI: 4.6/1 000-24.4/1 000) for children under five years old annually in Suzhou, which was close to the reported RSV hospitalization rate in literature (10/1 000-20/1 000). In the developed RSV HeaRT WeChat mini-program, target users (such as parents of children) could input basic information, disease history, and social environmental factors of the child into the mini-program, and the tool could provide real-time feedback on the following predicted results: First, the relative risk of hospitalization due to RSV infection in current children compared to general children; Second, the probability of hospitalization due to RSV infection within the next year; Third, the relative risk of adverse outcomes during hospitalization in the event of RSV infection. Conclusion: This study is based on real-world evidence related to RSV hospitalization risk and constructs an RSV hospitalization risk prediction model suitable for Chinese children based on the combination of the current prevalence of risk factors in children under five years old in China. The accuracy of the prediction model results has been preliminarily demonstrated. Based on this design, the RSV HeaRT developed can facilitate parents to evaluate the hospitalization risk of children.

目的:构建一个预测模型,以评估中国五岁以下儿童感染严重呼吸道合胞病毒的风险:构建评估中国五岁以下儿童严重呼吸道合胞病毒感染风险的预测模型,利用外部数据对该模型进行初步验证,并开发供家长使用的个人风险评估工具。方法将感染 RSV 后的入院时间作为严重感染的标志。根据RSV住院相关风险因素的证据和真实世界的数据,如中国5岁以下儿童各种风险因素的流行率,构建了基于蒙特卡洛的5岁以下儿童RSV住院风险预测模型。以苏州市为例,对模型进行了外部验证,并在微信小程序平台上开发了交互式风险预测工具(RSV HeaRT)。结果显示估算模型显示,在中国,如果人群不存在任何严重RSV感染的风险因素,5岁以下儿童的RSV年住院率为2.2/1000(95%CI:0.9/1000-7.5/1000)。根据这一基线住院率和相关风险因素在苏州的流行情况,模型预测苏州 5 岁以下儿童 RSV 年住院率为 8.0/1 000(95%CI:4.6/1 000-24.4/1 000),接近文献报道的 RSV 住院率(10/1 000-20/1 000)。在开发的RSV HeaRT微信小程序中,目标用户(如患儿家长)可将患儿的基本信息、疾病史、社会环境因素等输入小程序,工具可实时反馈以下预测结果:第一,与普通儿童相比,当前儿童因感染 RSV 而住院的相对风险;第二,未来一年内因感染 RSV 而住院的概率;第三,一旦感染 RSV,住院期间不良后果的相对风险。结论:本研究基于真实世界中与 RSV 住院风险相关的证据,结合目前中国 5 岁以下儿童的风险因素流行情况,构建了适合中国儿童的 RSV 住院风险预测模型。预测模型结果的准确性已得到初步验证。基于此设计开发的RSV HeaRT可帮助家长评估儿童的住院风险。
{"title":"[Development and validation of an individual risk prediction tool for severe respiratory syncytial virus infection among children under five years in China].","authors":"B B Cong, S Y Deng, S H Ma, Y M Miao, Y Li","doi":"10.3760/cma.j.cn112150-20231206-00406","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231206-00406","url":null,"abstract":"<p><p><b>Objective:</b> To construct a predictive model to assess the risk of severe respiratory syncytial virus infection among children under five years in China, conduct preliminary validation of this model by using external data, and develop an individual risk assessment tool available for their parents. <b>Methods:</b> The admission after RSV infection was used as a marker of severe infection. Based on the evidence of RSV hospitalization-related risk factors and real-world data, such as the prevalence of various risk factors in children under five years old in China, a Monte Carlo-based individual RSV hospitalization risk prediction model for children under five years old was constructed. Taking Suzhou City as an example, the model was externally validated, and an interactive risk prediction tool (RSV HeaRT) was developed on the WeChat mini-program platform. <b>Results:</b> The estimation model showed that in children under five years old in China if the population did not have any risk factors for severe RSV infection, the RSV annual hospitalization rate was 2.2/1 000 (95%<i>CI</i>: 0.9/1 000-7.5/1 000). Based on this baseline hospitalization rate and the prevalence of related risk factors in Suzhou, the model predicted an RSV hospitalization rate of 8.0/1 000 (95%<i>CI</i>: 4.6/1 000-24.4/1 000) for children under five years old annually in Suzhou, which was close to the reported RSV hospitalization rate in literature (10/1 000-20/1 000). In the developed RSV HeaRT WeChat mini-program, target users (such as parents of children) could input basic information, disease history, and social environmental factors of the child into the mini-program, and the tool could provide real-time feedback on the following predicted results: First, the relative risk of hospitalization due to RSV infection in current children compared to general children; Second, the probability of hospitalization due to RSV infection within the next year; Third, the relative risk of adverse outcomes during hospitalization in the event of RSV infection. <b>Conclusion:</b> This study is based on real-world evidence related to RSV hospitalization risk and constructs an RSV hospitalization risk prediction model suitable for Chinese children based on the combination of the current prevalence of risk factors in children under five years old in China. The accuracy of the prediction model results has been preliminarily demonstrated. Based on this design, the RSV HeaRT developed can facilitate parents to evaluate the hospitalization risk of children.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Age-period-cohort analysis of the mortality trend of dementia among elderly people aged 60 to 94 years in China from 1982 to 2021]. [1982-2021年中国60-94岁老年人痴呆死亡趋势的年龄-时期-队列分析]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231204-00395
Y Wei, B Liang, J J Li, X J Yan, L J Pei

Objective: To analyze the trend of dementia mortality rate among individuals aged 60 to 94 years in China from 1982 to 2021. Methods: Utilizing data from the Global Burden of Disease Study 2021, the Joinpoint regression model was employed to analyze the trend in the dementia mortality rate among Chinese older adults from 1982 to 2021. The age-period-cohort analysis method was used to decompose the age effect, period effect and cohort effect of dementia mortality data in Chinese elderly people. Results: From 1982 to 2021, the crude mortality rate of dementia in elderly women aged 60-94 in China (133.67/100 000-214.02/100 000) was higher than that in men (70.92/100 000-119.70/100 000), and the age-standardized mortality rate of dementia in women (230.74/100 000-246.87/100 000) was also higher than that in men (132.88/100 000-140.19/100 000). The age-standardized mortality rate of dementia in both genders showed an N-shaped fluctuation trend. The average annual percent change (AAPC) of dementia mortality rate in elderly males aged 60-94 was 0.07% (95%CI: 0.01%-0.13%), and the AAPC of dementia mortality rate in elderly females was -0.01% (95%CI:-0.08%-0.07%). Age effect analysis showed that from the age of 60, the risk of dementia death in males and females increased with age, especially among elderly people aged 75-94 who experienced a rapid increase in dementia mortality rate. The period effect analysis showed that the overall risk of dementia death in elderly men and women aged 60-94 was decreasing, but it had increased from 2017 to 2021. The cohort effect analysis showed that the risk of dementia death was lower in later birth cohorts. Conclusion: From 1982 to 2021, the dementia mortality rate among Chinese older adults aged 60 to 94 years exhibited fluctuations. Particularly, there has been a notable rebound in recent years. Special attention should be directed towards female seniors and those aged 75 to 94 years.

目的分析1982-2021年中国60-94岁人群痴呆死亡率的变化趋势。方法利用《2021 年全球疾病负担研究》的数据,采用 Joinpoint 回归模型分析 1982 年至 2021 年中国老年人痴呆死亡率的变化趋势。采用年龄-时期-队列分析方法对中国老年人痴呆死亡率数据的年龄效应、时期效应和队列效应进行分解。结果显示1982-2021年,中国60-94岁女性老年痴呆粗死亡率(133.67/100 000-214.02/100 000)高于男性(70.92/100 000-119.70/100 000),女性老年痴呆年龄标准化死亡率(230.74/100 000-246.87/100 000)也高于男性(132.88/100 000-140.19/100 000)。男女老年痴呆症的年龄标准化死亡率呈 N 型波动趋势。60-94岁老年男性痴呆症死亡率的年均百分率变化(AAPC)为0.07%(95%CI:0.01%-0.13%),老年女性痴呆症死亡率的年均百分率变化(AAPC)为-0.01%(95%CI:-0.08%-0.07%)。年龄效应分析表明,从 60 岁开始,男性和女性的痴呆症死亡风险随着年龄的增长而增加,尤其是 75-94 岁的老年人,其痴呆症死亡率迅速上升。时期效应分析表明,60-94 岁老年男性和女性的痴呆死亡风险总体呈下降趋势,但从 2017 年到 2021 年有所上升。队列效应分析表明,出生较晚的队列中痴呆症死亡风险较低。结论是从1982年到2021年,中国60至94岁老年人的痴呆死亡率呈现波动趋势。特别是近年来出现了明显的反弹。应特别关注女性老年人和 75 至 94 岁的老年人。
{"title":"[Age-period-cohort analysis of the mortality trend of dementia among elderly people aged 60 to 94 years in China from 1982 to 2021].","authors":"Y Wei, B Liang, J J Li, X J Yan, L J Pei","doi":"10.3760/cma.j.cn112150-20231204-00395","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231204-00395","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the trend of dementia mortality rate among individuals aged 60 to 94 years in China from 1982 to 2021. <b>Methods:</b> Utilizing data from the Global Burden of Disease Study 2021, the Joinpoint regression model was employed to analyze the trend in the dementia mortality rate among Chinese older adults from 1982 to 2021. The age-period-cohort analysis method was used to decompose the age effect, period effect and cohort effect of dementia mortality data in Chinese elderly people. <b>Results:</b> From 1982 to 2021, the crude mortality rate of dementia in elderly women aged 60-94 in China (133.67/100 000-214.02/100 000) was higher than that in men (70.92/100 000-119.70/100 000), and the age-standardized mortality rate of dementia in women (230.74/100 000-246.87/100 000) was also higher than that in men (132.88/100 000-140.19/100 000). The age-standardized mortality rate of dementia in both genders showed an N-shaped fluctuation trend. The average annual percent change (AAPC) of dementia mortality rate in elderly males aged 60-94 was 0.07% (95%<i>CI</i>: 0.01%-0.13%), and the AAPC of dementia mortality rate in elderly females was -0.01% (95%<i>CI</i>:-0.08%-0.07%). Age effect analysis showed that from the age of 60, the risk of dementia death in males and females increased with age, especially among elderly people aged 75-94 who experienced a rapid increase in dementia mortality rate. The period effect analysis showed that the overall risk of dementia death in elderly men and women aged 60-94 was decreasing, but it had increased from 2017 to 2021. The cohort effect analysis showed that the risk of dementia death was lower in later birth cohorts. <b>Conclusion:</b> From 1982 to 2021, the dementia mortality rate among Chinese older adults aged 60 to 94 years exhibited fluctuations. Particularly, there has been a notable rebound in recent years. Special attention should be directed towards female seniors and those aged 75 to 94 years.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of EXODUS system combined with allosteric DNA nanoswitches in the detection of miR-107 among plasma exosomes of Parkinson's disease patients]. [EXODUS系统与异构DNA纳米开关在检测帕金森病患者血浆外泌体中miR-107中的应用]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231205-00397
X Wang, L M Cheng

This study aimed to achieve rapid detection of Parkinson's disease (PD) plasma exosome miR-107. A case-control design was used to collect ten Parkinson's disease and ten healthy control plasma samples from the Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology from December 2023 to January 2024. Exosome detection via the ultrafast-isolation system (EXODUS) was used to isolate plasma exosomes. The nanoparticle tracking analysis technology and electron microscopy were used to identify exosome particle size and morphology. The Qiagen miRNeasy Micro Kit was used to extract RNA. The microRNA-activated conditional looping of engineered switches (miRacles) was used to detect miR-107, and the relative expression was analyzed by agarose gel electrophoresis. Thermo Fisher RevertAid RT Reverse Transcription Kit was used to perform reverse transcription of RNA, and real-time PCR was used to detect miR-107. The independent samples t-test was used for comparison between groups. EXODUS system completed the isolation of exosomes from 500 μl plasma within 1.5 hours. The exosome concentration (mean±SD) was (4.82±2.02)×1010 particles/ml in the control group and (5.08±2.34)×1010 particles/ml in the PD group. There was no significant difference in exosome concentration between PD patients and healthy controls (t=-0.168, P=0.872). The morphology of exosomes was confirmed by electron microscopy. The miRacles nanoswitch could detect fM-level miR-107 and also effectively distinguish miR-107 from its family members, including miR-15a and miR-16. Agarose gel electrophoresis showed that the mean±SD of relative grey value content was 1.00±0.26 in the control group and 1.86±0.21 in the PD group. The miR-107 in the PD group was significantly higher than that in the control (t=-8.143, P<0.001), which was consistent with the result of real-time PCR. EXODUS combined with miRacles could achieve rapid, non-enzymatic and cheap detection of plasma exosomal miR-107 in PD patients.

本研究旨在实现帕金森病(PD)血浆外泌体miR-107的快速检测。研究采用病例对照设计,于2023年12月至2024年1月在华中科技大学同济医学院附属同济医院检验科采集了10份帕金森病血浆样本和10份健康对照血浆样本。通过超快速分离系统(EXODUS)进行外泌体检测,以分离血浆外泌体。利用纳米粒子跟踪分析技术和电子显微镜鉴定外泌体的粒径和形态。使用 Qiagen miRNeasy Micro Kit 提取 RNA。利用microRNA激活的条件循环工程开关(miRacles)检测miR-107,并通过琼脂糖凝胶电泳分析其相对表达量。Thermo Fisher RevertAid RT 反转录试剂盒用于反转录 RNA,实时 PCR 用于检测 miR-107。组间比较采用独立样本 t 检验。EXODUS 系统可在 1.5 小时内从 500 μl 血浆中分离出外泌体。对照组的外泌体浓度(平均值±SD)为(4.82±2.02)×1010个/毫升,而腹膜透析组的外泌体浓度(平均值±SD)为(5.08±2.34)×1010个/毫升。PD患者与健康对照组的外泌体浓度无明显差异(t=-0.168,P=0.872)。电子显微镜证实了外泌体的形态。miRacles纳米开关能检测到fM级的miR-107,还能有效区分miR-107与其家族成员,包括miR-15a和miR-16。琼脂糖凝胶电泳显示,对照组相对灰度值的平均值(±SD)为(1.00±0.26),而腹泻组为(1.86±0.21)。PD组的miR-107明显高于对照组(t=-8.143,P
{"title":"[Application of EXODUS system combined with allosteric DNA nanoswitches in the detection of miR-107 among plasma exosomes of Parkinson's disease patients].","authors":"X Wang, L M Cheng","doi":"10.3760/cma.j.cn112150-20231205-00397","DOIUrl":"10.3760/cma.j.cn112150-20231205-00397","url":null,"abstract":"<p><p>This study aimed to achieve rapid detection of Parkinson's disease (PD) plasma exosome miR-107. A case-control design was used to collect ten Parkinson's disease and ten healthy control plasma samples from the Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology from December 2023 to January 2024. Exosome detection via the ultrafast-isolation system (EXODUS) was used to isolate plasma exosomes. The nanoparticle tracking analysis technology and electron microscopy were used to identify exosome particle size and morphology. The Qiagen miRNeasy Micro Kit was used to extract RNA. The microRNA-activated conditional looping of engineered switches (miRacles) was used to detect miR-107, and the relative expression was analyzed by agarose gel electrophoresis. Thermo Fisher RevertAid RT Reverse Transcription Kit was used to perform reverse transcription of RNA, and real-time PCR was used to detect miR-107. The independent samples t-test was used for comparison between groups. EXODUS system completed the isolation of exosomes from 500 μl plasma within 1.5 hours. The exosome concentration (mean±SD) was (4.82±2.02)×10<sup>10</sup> particles/ml in the control group and (5.08±2.34)×10<sup>10</sup> particles/ml in the PD group. There was no significant difference in exosome concentration between PD patients and healthy controls (<i>t</i>=-0.168, <i>P</i>=0.872). The morphology of exosomes was confirmed by electron microscopy. The miRacles nanoswitch could detect fM-level miR-107 and also effectively distinguish miR-107 from its family members, including miR-15a and miR-16. Agarose gel electrophoresis showed that the mean±SD of relative grey value content was 1.00±0.26 in the control group and 1.86±0.21 in the PD group. The miR-107 in the PD group was significantly higher than that in the control (<i>t</i>=-8.143, <i>P</i><0.001), which was consistent with the result of real-time PCR. EXODUS combined with miRacles could achieve rapid, non-enzymatic and cheap detection of plasma exosomal miR-107 in PD patients.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in the diagnosis and poor prognosis of diabetic hyperfiltration]. [糖尿病高滤过诊断和不良预后的进展]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240108-00027
R X Ma, X J Wang, D Q Peng

Glomerular hyperfiltration(GHF), as an early manifestation of prediabetes and diabetic kidney disease, occurs mainly by the mechanism of glomerular-tubular feedback and hemodynamic alterations, and the risk of hyperfiltration can be elevated in younger patients, shorter duration of the disease, poor glycemic control, and high-protein, low-salt diet. Currently, there is no recognized standard for the definition of GHF, GHF lacks typical clinical manifestations, imaging diagnostic criteria are unclear, and GHF-related laboratory markers need to be further studied. Hyperfiltration, if not diagnosed and intervened in time, can accelerate the damage of nephron and the rate of nephropathy progression, and increase the risk of complications and death. Sodium-glucose cotransporter 2 inhibitor(SGLT2i), glucagon-like peptide-1 receptor agonist(GLP-1RA)and so on can effectively reverse the hyperfiltration state. Clinical attention should be paid to the diagnosis of diabetic hyperfiltration and the prevention of its poor prognosis.

肾小球高滤过(GHF)是糖尿病前期和糖尿病肾病的早期表现,主要通过肾小球-肾小管反馈机制和血液动力学改变发生,年轻患者、病程较短、血糖控制不佳、高蛋白低盐饮食者发生高滤过的风险会升高。目前,GHF 的定义还没有公认的标准,GHF 缺乏典型的临床表现,影像学诊断标准不明确,GHF 相关的实验室指标也有待进一步研究。高滤过如果不及时诊断和干预,会加速肾小球的损伤和肾病的进展速度,增加并发症和死亡的风险。钠-葡萄糖共转运体2抑制剂(SGLT2i)、胰高血糖素样肽-1受体激动剂(GLP-1RA)等可有效逆转高滤过状态。临床上应重视糖尿病高滤过的诊断和预防其不良预后。
{"title":"[Advances in the diagnosis and poor prognosis of diabetic hyperfiltration].","authors":"R X Ma, X J Wang, D Q Peng","doi":"10.3760/cma.j.cn112150-20240108-00027","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240108-00027","url":null,"abstract":"<p><p>Glomerular hyperfiltration(GHF), as an early manifestation of prediabetes and diabetic kidney disease, occurs mainly by the mechanism of glomerular-tubular feedback and hemodynamic alterations, and the risk of hyperfiltration can be elevated in younger patients, shorter duration of the disease, poor glycemic control, and high-protein, low-salt diet. Currently, there is no recognized standard for the definition of GHF, GHF lacks typical clinical manifestations, imaging diagnostic criteria are unclear, and GHF-related laboratory markers need to be further studied. Hyperfiltration, if not diagnosed and intervened in time, can accelerate the damage of nephron and the rate of nephropathy progression, and increase the risk of complications and death. Sodium-glucose cotransporter 2 inhibitor(SGLT2i), glucagon-like peptide-1 receptor agonist(GLP-1RA)and so on can effectively reverse the hyperfiltration state. Clinical attention should be paid to the diagnosis of diabetic hyperfiltration and the prevention of its poor prognosis.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The application of the diagnosis and therapy of single cell sequencing technology in central nervous system tumors]. [单细胞测序技术在中枢神经系统肿瘤诊断和治疗中的应用]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231208-00417
H Y Ruan, M Guan

Central nervous system (CNS) tumors have complex causes and poor prognosis. Tumor heterogeneity is a major cause of treatment failure, and in-depth understanding of the biodiversity of CNS tumors is critical. Single-cell sequencing technology provides an opportunity to reveal the complex ecosystem of CNS tumors. In this study, we review the significance of single-cell sequencing in exploring the heterogeneity, diagnosis, treatment, and prognosis of CNS tumors from three aspects: tumor stem cells, tumor microenvironment, and cerebrospinal fluid. Although most of the findings have not been clinically applicable, they lay the foundation for the development of new guidelines for CNS tumors that help improve tumor prognosis and prevent tumor recurrence.

中枢神经系统(CNS)肿瘤病因复杂,预后不良。肿瘤异质性是治疗失败的主要原因,因此深入了解中枢神经系统肿瘤的生物多样性至关重要。单细胞测序技术为揭示中枢神经系统肿瘤复杂的生态系统提供了机会。在本研究中,我们从肿瘤干细胞、肿瘤微环境和脑脊液三个方面综述了单细胞测序在探索中枢神经系统肿瘤的异质性、诊断、治疗和预后方面的意义。虽然大部分研究结果尚未应用于临床,但它们为制定中枢神经系统肿瘤的新指南奠定了基础,有助于改善肿瘤预后和预防肿瘤复发。
{"title":"[The application of the diagnosis and therapy of single cell sequencing technology in central nervous system tumors].","authors":"H Y Ruan, M Guan","doi":"10.3760/cma.j.cn112150-20231208-00417","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231208-00417","url":null,"abstract":"<p><p>Central nervous system (CNS) tumors have complex causes and poor prognosis. Tumor heterogeneity is a major cause of treatment failure, and in-depth understanding of the biodiversity of CNS tumors is critical. Single-cell sequencing technology provides an opportunity to reveal the complex ecosystem of CNS tumors. In this study, we review the significance of single-cell sequencing in exploring the heterogeneity, diagnosis, treatment, and prognosis of CNS tumors from three aspects: tumor stem cells, tumor microenvironment, and cerebrospinal fluid. Although most of the findings have not been clinically applicable, they lay the foundation for the development of new guidelines for CNS tumors that help improve tumor prognosis and prevent tumor recurrence.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of human respiratory syncytial virus in patients with severe acute respiratory infection in Tianjin City from 2015 to 2020]. [2015-2020年天津市重症急性呼吸道感染患者人呼吸道合胞病毒流行病学特征]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240117-00064
C Su, J Yang, F Z Yan, L Li, Z B Peng, Y Zhang

Objective: To investigate the epidemiological characteristics of human respiratory syncytial virus (HRSV) in patients with Severe Acute Respiratory Infection (SARI) in Tianjin from 2015 to 2020. Methods: The study data were obtained from the Third Center Hospital of Tianjin, a designated sentinel hospital, from 2015 to 2020, with 1 597 SARI patients enrolled in this study. The clinical specimens of the research participants were subjected to respiratory multi-pathogen testing. HRSV-positive specimens were subtyped to analyze the differences in HRSV detection rates among cases of different age groups and periods and their mixed infection situations. Results: A total of 1 597 nasopharyngeal swabs were collected, with an HRSV detection rate of 4.20%. Among 67 HRSV-positive specimens, there were 19 pure HRSV-A nucleic acid-positive specimens, 19 pure HRSV-B nucleic acid-positive specimens and 29 mixed HRSV-A and HRSV-B nucleic acid-positive specimens. The difference in HRSV detection rate among different age groups was statistically significant (P<0.05), and the HRSV detection rate in children under five years old was higher than that in other age groups. From 2016 to 2020, the detection rate of HRSV showed an increasing trend year by year. The HRSV detection rate of SARI cases was highest in the winter season, at 7.15%. There were 10 (14.93%) mixed positive cases for HRSV and other viruses, of which four were mixed positive for HRSV and influenza A. Conclusion: The incidence of HRSV in Tianjin exhibits an increasing trend from 2016 to 2020, peaking during the winter season, with children under five years old constituting a high-risk demographic for HRSV infection.

目的研究2015-2020年天津市严重急性呼吸道感染(SARI)患者中人类呼吸道合胞病毒(HRSV)的流行病学特征。研究方法研究数据来自定点哨点医院--天津市第三中心医院,从2015年至2020年,共有1 597名SARI患者纳入本研究。研究参与者的临床标本接受了呼吸道多病原体检测。对HRSV阳性标本进行分型,分析不同年龄段、不同时期病例及其混合感染情况下HRSV检出率的差异。结果共采集鼻咽拭子 1 597 份,HRSV 检出率为 4.20%。在 67 份 HRSV 阳性标本中,纯 HRSV-A 核酸阳性标本 19 份,纯 HRSV-B 核酸阳性标本 19 份,HRSV-A 和 HRSV-B 混合核酸阳性标本 29 份。不同年龄组的 HRSV 检出率差异有统计学意义(PC 结论:HRSV-A 和 HRSV-B 核酸阳性标本的检出率差异有统计学意义(P<0.05):从2016年到2020年,天津市HRSV发病率呈上升趋势,在冬季达到高峰,5岁以下儿童是HRSV感染的高危人群。
{"title":"[Epidemiological characteristics of human respiratory syncytial virus in patients with severe acute respiratory infection in Tianjin City from 2015 to 2020].","authors":"C Su, J Yang, F Z Yan, L Li, Z B Peng, Y Zhang","doi":"10.3760/cma.j.cn112150-20240117-00064","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240117-00064","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the epidemiological characteristics of human respiratory syncytial virus (HRSV) in patients with Severe Acute Respiratory Infection (SARI) in Tianjin from 2015 to 2020. <b>Methods:</b> The study data were obtained from the Third Center Hospital of Tianjin, a designated sentinel hospital, from 2015 to 2020, with 1 597 SARI patients enrolled in this study. The clinical specimens of the research participants were subjected to respiratory multi-pathogen testing. HRSV-positive specimens were subtyped to analyze the differences in HRSV detection rates among cases of different age groups and periods and their mixed infection situations. <b>Results:</b> A total of 1 597 nasopharyngeal swabs were collected, with an HRSV detection rate of 4.20%. Among 67 HRSV-positive specimens, there were 19 pure HRSV-A nucleic acid-positive specimens, 19 pure HRSV-B nucleic acid-positive specimens and 29 mixed HRSV-A and HRSV-B nucleic acid-positive specimens. The difference in HRSV detection rate among different age groups was statistically significant (<i>P</i><0.05), and the HRSV detection rate in children under five years old was higher than that in other age groups. From 2016 to 2020, the detection rate of HRSV showed an increasing trend year by year. The HRSV detection rate of SARI cases was highest in the winter season, at 7.15%. There were 10 (14.93%) mixed positive cases for HRSV and other viruses, of which four were mixed positive for HRSV and influenza A. <b>Conclusion:</b> The incidence of HRSV in Tianjin exhibits an increasing trend from 2016 to 2020, peaking during the winter season, with children under five years old constituting a high-risk demographic for HRSV infection.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological and clinical characteristics of respiratory syncytial virus infection among people aged 60 and above in Beijing City]. [北京市 60 岁及以上老年人呼吸道合胞病毒感染的流行病学和临床特征]。
Q3 Medicine Pub Date : 2024-07-06 DOI: 10.3760/cma.j.cn112150-20240117-00065
X F Wei, M Z Li, Y T Wang, Q Huang, C Gong, L D Suo, F Huang

Objective: To investigate the epidemiological and clinical characteristics of RSV among patients aged ≥60 years in Beijing from 2015 to 2023. Methods: Based on the respiratory pathogen surveillance system, samples of upper respiratory tract infections (URTI), non-severe community-acquired pneumonia (nsCAP) and severe community-acquired pneumonia (sCAP) among people aged ≥60 years were collected from 28 sentinel hospitals in 16 districts of Beijing from January 2015 to December 2023. Swab samples were collected from URTI within one week, and lower respiratory tract samples from nsCAP and sCAP were collected. Demographic and epidemiological data were also collected. Various respiratory pathogens including RSV were detected. Results: From January 2015 to December 2023, a total of 20 349 cases of acute respiratory infections aged ≥60 years were included, with the RSV-positive rate of 1.54% (313/20 349, 95%CI: 1.39%-1.68%). Among them, the total RSV-positive rates of older people during the pre-pandemic, pandemic, and post-pandemic periods of COVID-19 were 1.59% (207/13 006, 95%CI: 1.38%-1.81%), 0.82% (38/4 650, 95%CI: 0.56%-1.08%) and 2.53% (68/2 693, 95%CI: 1.93%-3.12%), respectively. The difference in RSV-positive rate was statistically significant (P<0.001). Based on the sampling time of cases, the RSV epidemic season for older people in Beijing was from October to March of the following year, with a peak period in December or January of the following year. In the post COVID-19 pandemic, there were very few RSV-positive cases detected in the elderly from April to June 2023, with only one positive case detected in May and one in June. The RSV-positive rate of older people increased significantly from October to December, reaching 11.75% (51/383) in December. Among 263 RSV-positive cases in the elderly, RSV-A, RSV-B and unclassified type accounted for 43.35% (114/263), 29.28% (77/263) and 27.38% (72/263), respectively. Since 2020, there has been a subtype conversion, with RSV-B being the main focus. Among 197 elderly cases that have complete clinical data, the main symptoms were cough (86.8%, 171/197), sputum (80.2%, 158/197) and fever (73.60%, 145/197). About 24.87% (49/197) of elderly cases experienced complications. The hospitalization mortality rate was 4.57% (9/197), and the hospitalization rate was 78.68% (155/197). The ICU occupancy rate was 1.99% (36/197). The mechanical ventilation usage rate was 13.32% (33/197), and the length of hospital stay [M (Q1, Q3)] was 12 (9, 16) days. Conclusion: In Beijing, the RSV infection rate is relatively low during the COVID-19 pandemic, and the prevalence of COVID-19 is relatively high. In 2023, there was no out-of-season outbreak of RSV infection among the elderly. Elderly RSV infection cases have multiple complications, severe diseases, and poor prognosis.

目的调查 2015 年至 2023 年北京市≥60 岁患者 RSV 的流行病学和临床特征。方法基于呼吸道病原体监测系统,从 2015 年 1 月至 2023 年 12 月,在北京市 16 个区的 28 家哨点医院采集年龄≥60 岁人群的上呼吸道感染(URTI)、非重症社区获得性肺炎(nsCAP)和重症社区获得性肺炎(sCAP)样本。在一周内采集 URTI 的拭子样本,并采集 nsCAP 和 sCAP 的下呼吸道样本。同时还收集了人口统计学和流行病学数据。检测了包括 RSV 在内的各种呼吸道病原体。结果:从 2015 年 1 月至 2023 年 12 月,共纳入 20 349 例年龄≥60 岁的急性呼吸道感染病例,RSV 阳性率为 1.54%(313/20 349,95%CI:1.39%-1.68%)。其中,在 COVID-19 大流行前、大流行期间和大流行后,老年人 RSV 阳性率分别为 1.59%(207/13 006,95%CI:1.38%-1.81%)、0.82%(38/4 650,95%CI:0.56%-1.08%)和 2.53%(68/2 693,95%CI:1.93%-3.12%)。RSV 阳性率的差异具有统计学意义(PM(Q1,Q3)]为 12(9,16)天。结论在 COVID-19 大流行期间,北京的 RSV 感染率相对较低,而 COVID-19 的流行率相对较高。2023 年,老年人 RSV 感染未出现季节外暴发。老年 RSV 感染病例并发症多、病情重、预后差。
{"title":"[Epidemiological and clinical characteristics of respiratory syncytial virus infection among people aged 60 and above in Beijing City].","authors":"X F Wei, M Z Li, Y T Wang, Q Huang, C Gong, L D Suo, F Huang","doi":"10.3760/cma.j.cn112150-20240117-00065","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240117-00065","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the epidemiological and clinical characteristics of RSV among patients aged ≥60 years in Beijing from 2015 to 2023. <b>Methods:</b> Based on the respiratory pathogen surveillance system, samples of upper respiratory tract infections (URTI), non-severe community-acquired pneumonia (nsCAP) and severe community-acquired pneumonia (sCAP) among people aged ≥60 years were collected from 28 sentinel hospitals in 16 districts of Beijing from January 2015 to December 2023. Swab samples were collected from URTI within one week, and lower respiratory tract samples from nsCAP and sCAP were collected. Demographic and epidemiological data were also collected. Various respiratory pathogens including RSV were detected. <b>Results:</b> From January 2015 to December 2023, a total of 20 349 cases of acute respiratory infections aged ≥60 years were included, with the RSV-positive rate of 1.54% (313/20 349, 95%<i>CI</i>: 1.39%-1.68%). Among them, the total RSV-positive rates of older people during the pre-pandemic, pandemic, and post-pandemic periods of COVID-19 were 1.59% (207/13 006, 95%<i>CI</i>: 1.38%-1.81%), 0.82% (38/4 650, 95%<i>CI</i>: 0.56%-1.08%) and 2.53% (68/2 693, 95%<i>CI</i>: 1.93%-3.12%), respectively. The difference in RSV-positive rate was statistically significant (<i>P</i><0.001). Based on the sampling time of cases, the RSV epidemic season for older people in Beijing was from October to March of the following year, with a peak period in December or January of the following year. In the post COVID-19 pandemic, there were very few RSV-positive cases detected in the elderly from April to June 2023, with only one positive case detected in May and one in June. The RSV-positive rate of older people increased significantly from October to December, reaching 11.75% (51/383) in December. Among 263 RSV-positive cases in the elderly, RSV-A, RSV-B and unclassified type accounted for 43.35% (114/263), 29.28% (77/263) and 27.38% (72/263), respectively. Since 2020, there has been a subtype conversion, with RSV-B being the main focus. Among 197 elderly cases that have complete clinical data, the main symptoms were cough (86.8%, 171/197), sputum (80.2%, 158/197) and fever (73.60%, 145/197). About 24.87% (49/197) of elderly cases experienced complications. The hospitalization mortality rate was 4.57% (9/197), and the hospitalization rate was 78.68% (155/197). The ICU occupancy rate was 1.99% (36/197). The mechanical ventilation usage rate was 13.32% (33/197), and the length of hospital stay [<i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>)] was 12 (9, 16) days. <b>Conclusion:</b> In Beijing, the RSV infection rate is relatively low during the COVID-19 pandemic, and the prevalence of COVID-19 is relatively high. In 2023, there was no out-of-season outbreak of RSV infection among the elderly. Elderly RSV infection cases have multiple complications, severe diseases, and poor prognosis.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in electrowetting-on-dielectric digital microfluidics technology for disease diagnosis and prevention applications]. [用于疾病诊断和预防的电介质上电泳数字微流控技术的进展]。
Q3 Medicine Pub Date : 2024-07-06 DOI: 10.3760/cma.j.cn112150-20231225-00492
W J Zhu, L Wang, W Xia, X L Wang, J Jin, X Wang, Y Lu, Y Chen

Rapid and accurate diagnostic technologies are crucial for early detection and diagnosis of diseases. Electrowetting-on-dielectric digital microfluidics, with its high-precision detection and high-throughput screening capabilities, significantly enhances the accuracy and efficiency in early disease diagnosis and personalized treatment, enabling swift disease detection and widespread screening. This article provides a comprehensive review of the working principles and fabrication processes of digital microfluidic chips based on electrowetting on dielectric method. It details the latest research progress in the areas of nucleic acids, proteins, and cells, organizes the commercialization of digital microfluidics technology, and finally discusses the current challenges and future directions of digital microfluidic chips.

快速准确的诊断技术对于疾病的早期检测和诊断至关重要。电介质电润湿数字微流控芯片具有高精度检测和高通量筛查能力,可显著提高疾病早期诊断和个性化治疗的准确性和效率,实现疾病的快速检测和广泛筛查。本文全面综述了基于电介质电润湿法的数字微流控芯片的工作原理和制造工艺。文章详细介绍了核酸、蛋白质和细胞领域的最新研究进展,对数字微流控技术的商业化进行了梳理,最后讨论了数字微流控芯片当前面临的挑战和未来的发展方向。
{"title":"[Advances in electrowetting-on-dielectric digital microfluidics technology for disease diagnosis and prevention applications].","authors":"W J Zhu, L Wang, W Xia, X L Wang, J Jin, X Wang, Y Lu, Y Chen","doi":"10.3760/cma.j.cn112150-20231225-00492","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231225-00492","url":null,"abstract":"<p><p>Rapid and accurate diagnostic technologies are crucial for early detection and diagnosis of diseases. Electrowetting-on-dielectric digital microfluidics, with its high-precision detection and high-throughput screening capabilities, significantly enhances the accuracy and efficiency in early disease diagnosis and personalized treatment, enabling swift disease detection and widespread screening. This article provides a comprehensive review of the working principles and fabrication processes of digital microfluidic chips based on electrowetting on dielectric method. It details the latest research progress in the areas of nucleic acids, proteins, and cells, organizes the commercialization of digital microfluidics technology, and finally discusses the current challenges and future directions of digital microfluidic chips.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on the application value of fecal SDC2 gene methylation detection in colorectal cancer screening of urban residents in Zengcheng District in Guangzhou City]. [粪便 SDC2 基因甲基化检测在广州市增城区城镇居民大肠癌筛查中的应用价值研究]。
Q3 Medicine Pub Date : 2024-07-06 DOI: 10.3760/cma.j.cn112150-20240116-00056
Y He, F F Xu, H J Zuo, W Chen, Z B Liu, Z B Liu, X Z Chen, Q S Hui, G W Zou, Z B Cai, Y Liu, H S Tan, H F Zhou, J P Wang

Objective: To investigate the application value of fecal Syndecan-2 (SDC2) gene methylated SDC2 (mSDC2) detection in colorectal cancer (CRC) screening among urban residents in Guangzhou City. Methods: A cross-sectional study was conducted in Shitan Town, Zengcheng District, Guangzhou City from July to December 2022. A community-based screening program for CRC was conducted among residents aged 40-74 years old. mSDC2 detection was employed in the participants, and those with positive results should be recommended to receive colonoscopy examination. The positive rate of mSDC2 detection, colonoscopy compliance rate, detection rate of intestinal lesions and clinicopathological characteristics were observed. The relationship between cycle threshold (CT) value of mSDC2 and intestinal lesions was explored. Further, the cost-effectiveness of screening was evaluated. Results: A total of 8 189 fecal samples were collected from 8 877 participants with the recovery rate of 92.25%. 8 048 qualified samples were enrolled in this study, consisted of 3 182 males (39.54%) and 4 866 females (60.46%), with the average age of 56 years old (40-74 years). The positive rate of mSDC2 detection was 7.99% (643/8 048), and the compliance rate of colonoscopy was 73.10% (470/643). 20 cases (4.25%) of colorectal cancer, 109 cases (23.19%) of advanced adenoma, 145 cases (30.85%) of non-advanced adenoma, 79 cases (16.81%) of polyps were detected. The detection rate of intestinal lesions was 75.11% and indicated significant differences in gender and age. 20 CRCs included 15 of stage 0-I, 4 of stage Ⅱ-Ⅲ and 1 of unknown stage. The CT value of mSDC2 was negatively correlated with the proportion of advanced colorectal neoplasms (χ2=16.063, P<0.001). The total cost of the screening was 4.339 5 million yuan, the screening benefit was 28.506 2 million yuan, and the benefit-cost ratio was 6.57. Conclusion: The CRC screening strategy of fecal mSDC2 detection combined with colonoscopy has high colonoscopy compliance and detection rate of intestinal lesions, which is conducive to the detection of early CRCs, and has good cost-effectiveness. This study suggests that this method may be applied to the general CRC screening in China and contribute to the prevention of CRC. The CT value of mSDC2 may have a certain suggestion on the malignant degree of intestinal tumors.

目的探讨粪便Syndecan-2(SDC2)基因甲基化SDC2(mSDC2)检测在广州市城市居民大肠癌(CRC)筛查中的应用价值。研究方法于2022年7月至12月在广州市增城区石滩镇开展了一项横断面研究。对参与者进行 mSDC2 检测,并建议阳性者接受结肠镜检查。观察了 mSDC2 检测的阳性率、结肠镜检查达标率、肠道病变检出率和临床病理特征。研究还探讨了 mSDC2 周期阈值(CT)与肠道病变之间的关系。此外,还评估了筛查的成本效益。结果共收集了 8 877 名参与者的 8 189 份粪便样本,回收率为 92.25%。8 048 份合格样本被纳入本研究,其中男性 3 182 人(39.54%),女性 4 866 人(60.46%),平均年龄 56 岁(40-74 岁)。mSDC2 检测阳性率为 7.99%(643/8 048),结肠镜检查符合率为 73.10%(470/643)。检出大肠癌 20 例(4.25%)、晚期腺瘤 109 例(23.19%)、非晚期腺瘤 145 例(30.85%)、息肉 79 例(16.81%)。肠道病变的检出率为 75.11%,性别和年龄差异显著。20 例 CRC 中,0-Ⅰ期 15 例,Ⅱ-Ⅲ期 4 例,未知期 1 例。mSDC2 的 CT 值与晚期结直肠肿瘤的比例呈负相关(χ2=16.063,P0.001)。筛查总成本为 433.95 万元,筛查收益为 2850.62 万元,收益成本比为 6.57。结论粪便 mSDC2 检测联合结肠镜检查的 CRC 筛查策略具有较高的结肠镜检查依从性和肠道病变检出率,有利于早期 CRC 的检出,且具有良好的成本效益。本研究提示,该方法可应用于中国的普通 CRC 筛查,为预防 CRC 的发生做出贡献。mSDC2的CT值可能对肠道肿瘤的恶性程度有一定的提示作用。
{"title":"[Study on the application value of fecal <i>SDC2</i> gene methylation detection in colorectal cancer screening of urban residents in Zengcheng District in Guangzhou City].","authors":"Y He, F F Xu, H J Zuo, W Chen, Z B Liu, Z B Liu, X Z Chen, Q S Hui, G W Zou, Z B Cai, Y Liu, H S Tan, H F Zhou, J P Wang","doi":"10.3760/cma.j.cn112150-20240116-00056","DOIUrl":"10.3760/cma.j.cn112150-20240116-00056","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the application value of fecal Syndecan-2 (SDC2) gene methylated <i>SDC2</i> (m<i>SDC2</i>) detection in colorectal cancer (CRC) screening among urban residents in Guangzhou City. <b>Methods:</b> A cross-sectional study was conducted in Shitan Town, Zengcheng District, Guangzhou City from July to December 2022. A community-based screening program for CRC was conducted among residents aged 40-74 years old. m<i>SDC2</i> detection was employed in the participants, and those with positive results should be recommended to receive colonoscopy examination. The positive rate of m<i>SDC2</i> detection, colonoscopy compliance rate, detection rate of intestinal lesions and clinicopathological characteristics were observed. The relationship between cycle threshold (CT) value of m<i>SDC2</i> and intestinal lesions was explored. Further, the cost-effectiveness of screening was evaluated. <b>Results:</b> A total of 8 189 fecal samples were collected from 8 877 participants with the recovery rate of 92.25%. 8 048 qualified samples were enrolled in this study, consisted of 3 182 males (39.54%) and 4 866 females (60.46%), with the average age of 56 years old (40-74 years). The positive rate of m<i>SDC2</i> detection was 7.99% (643/8 048), and the compliance rate of colonoscopy was 73.10% (470/643). 20 cases (4.25%) of colorectal cancer, 109 cases (23.19%) of advanced adenoma, 145 cases (30.85%) of non-advanced adenoma, 79 cases (16.81%) of polyps were detected. The detection rate of intestinal lesions was 75.11% and indicated significant differences in gender and age. 20 CRCs included 15 of stage 0-I, 4 of stage Ⅱ-Ⅲ and 1 of unknown stage. The CT value of m<i>SDC2</i> was negatively correlated with the proportion of advanced colorectal neoplasms (<i>χ</i><sup>2</sup>=16.063, <i>P<</i>0.001). The total cost of the screening was 4.339 5 million yuan, the screening benefit was 28.506 2 million yuan, and the benefit-cost ratio was 6.57. <b>Conclusion:</b> The CRC screening strategy of fecal m<i>SDC2</i> detection combined with colonoscopy has high colonoscopy compliance and detection rate of intestinal lesions, which is conducive to the detection of early CRCs, and has good cost-effectiveness. This study suggests that this method may be applied to the general CRC screening in China and contribute to the prevention of CRC. The CT value of m<i>SDC2</i> may have a certain suggestion on the malignant degree of intestinal tumors.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Establishment and preliminary application of neutralizing antibody detection method for human respiratory syncytial virus]. [人类呼吸道合胞病毒中和抗体检测方法的建立和初步应用]。
Q3 Medicine Pub Date : 2024-07-06 DOI: 10.3760/cma.j.cn112150-20240102-00004
L Zhang, H Li, L Cao, H Q Hu, N Wang, H X Li, J Jiang, N Y Mao, X M Li, Y Zhang

Objective: To establish a Plaque-reduction Neutralization Test (PRNT) for the detection of neutralizing antibody titers of Human Respiratory Syncytial Virus (HRSV) and optimize the conditions for preliminary application. Methods: The CHO expression system was used to produce palivizumab monoclonal antibody (palivizumab) and the influencing factors such as cell type, cell culture duration, fixation and permeabilization protocols, and blocking agents. The reproducibility of the method was verified and its correlation was verified with conventional PRNT. Finally, the optimized PRNT assay was further used to determine neutralizing antibody titers against HRSV subtypes A and B in BALB/c mouse serum (immunized by intramuscular injection of HRSV fusion proteins). Results: Palivizumab was expressed at approximately 50 mg/L. The optimal working conditions for PRNT were as follows: culturing HEp-2 cells for 2 days, fixing with 4% (V/V) paraformaldehyde at room temperature for 15 min followed by 0.2% (V/V) Triton X-100 permeabilization for 15 minutes as the optimal fixation-permeabilization and removing the blocking step. The overall coefficient of variation (CV) for the reproducibility validation of this method was <15%, showing a good linear relationship with the conventional PRNT. The Spearman correlation coefficient rs was 0.983. This method was used to detect neutralizing antibody titers in mouse sera against HRSV subtype A strain long and subtype B strain 9320, and the fusion proteins combined with AlOH and CpG adjuvant induced the highest neutralizing antibody titers in mice. Conclusion: The HRSV neutralizing antibody assay established in this study is rapid, reproducible, high-throughput, and can be used to detect neutralizing antibodies to HRSV subtypes A and B.

目的建立用于检测人类呼吸道合胞病毒(HRSV)中和抗体滴度的斑块还原中和试验(PRNT),并优化初步应用的条件。方法:采用CHO表达系统制备帕利珠单抗(palivizumab),并对细胞类型、细胞培养时间、固定和通透方案、阻断剂等影响因素进行了分析。该方法的重现性得到了验证,其与传统 PRNT 的相关性也得到了验证。最后,进一步使用优化的 PRNT 方法测定了 BALB/c 小鼠血清(通过肌肉注射 HRSV 融合蛋白进行免疫)中针对 HRSV A 和 B 亚型的中和抗体滴度。结果帕利珠单抗的表达量约为 50 mg/L。PRNT 的最佳工作条件如下:培养 HEp-2 细胞 2 天,室温下用 4%(V/V)多聚甲醛固定 15 分钟,然后用 0.2%(V/V)Triton X-100 通透 15 分钟,作为最佳固定-通透条件,并去除阻断步骤。该方法重现性验证的总体变异系数(CV)为 0.983。用该方法检测了小鼠血清中针对 HRSV A 亚型长毒株和 B 亚型 9320 毒株的中和抗体滴度,融合蛋白与 AlOH 和 CpG 佐剂结合诱导的小鼠中和抗体滴度最高。结论本研究建立的 HRSV 中和抗体检测方法快速、可重复、高通量,可用于检测 HRSV A 和 B 亚型的中和抗体。
{"title":"[Establishment and preliminary application of neutralizing antibody detection method for human respiratory syncytial virus].","authors":"L Zhang, H Li, L Cao, H Q Hu, N Wang, H X Li, J Jiang, N Y Mao, X M Li, Y Zhang","doi":"10.3760/cma.j.cn112150-20240102-00004","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240102-00004","url":null,"abstract":"<p><p><b>Objective:</b> To establish a Plaque-reduction Neutralization Test (PRNT) for the detection of neutralizing antibody titers of Human Respiratory Syncytial Virus (HRSV) and optimize the conditions for preliminary application. <b>Methods:</b> The CHO expression system was used to produce palivizumab monoclonal antibody (palivizumab) and the influencing factors such as cell type, cell culture duration, fixation and permeabilization protocols, and blocking agents. The reproducibility of the method was verified and its correlation was verified with conventional PRNT. Finally, the optimized PRNT assay was further used to determine neutralizing antibody titers against HRSV subtypes A and B in BALB/c mouse serum (immunized by intramuscular injection of HRSV fusion proteins). <b>Results:</b> Palivizumab was expressed at approximately 50 mg/L. The optimal working conditions for PRNT were as follows: culturing HEp-2 cells for 2 days, fixing with 4% (V/V) paraformaldehyde at room temperature for 15 min followed by 0.2% (V/V) Triton X-100 permeabilization for 15 minutes as the optimal fixation-permeabilization and removing the blocking step. The overall coefficient of variation (CV) for the reproducibility validation of this method was <15%, showing a good linear relationship with the conventional PRNT. The Spearman correlation coefficient <i>r<sub>s</sub></i> was 0.983. This method was used to detect neutralizing antibody titers in mouse sera against HRSV subtype A strain long and subtype B strain 9320, and the fusion proteins combined with AlOH and CpG adjuvant induced the highest neutralizing antibody titers in mice. <b>Conclusion:</b> The HRSV neutralizing antibody assay established in this study is rapid, reproducible, high-throughput, and can be used to detect neutralizing antibodies to HRSV subtypes A and B.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1